Expansion would make DaVita the largest
dialysis services provider in Latin
America
DENVER, March 5, 2024 /PRNewswire/ -- DaVita Inc (NYSE:
DVA), a leading provider of kidney care services, today announced
that it has agreed to terms on the expansion of its international
operations in Brazil and
Colombia, and its entry into
Chile and Ecuador. The deal, which is consistent with
DaVita's disciplined investment strategy, involves four separate
acquisitions from Fresenius Medical Care for a total purchase price
of $300M USD. The transaction in
Chile closed effective today. The
transactions in Ecuador,
Colombia and Brazil remain subject to each country's
respective anti-trust and regulatory approval processes, which are
each expected to be completed at various times during 2024.
Upon completion of the transactions and when combined with
DaVita's existing Latin American operations in Brazil and Colombia, the Company will have more than
15,000 DaVita teammates providing high-quality clinical care to
more than 60,000 patients in more than 270 clinics. As a result,
DaVita would become the largest dialysis services provider in
Latin America.
"As we welcome thousands of dedicated caregivers to DaVita, we
will continue our strategy of combining our global clinical
expertise with strong investment in our local teams to deliver a
sustainable and valuable contribution to the healthcare communities
we serve," said Robert Lang,
president of DaVita International. "Delivering outstanding clinical
care for individuals suffering from kidney disease is our most
important priority. We look forward to building on our existing
market expertise and the established quality of these centers
through this transition."
DaVita's international operations provide life-sustaining care
in 12 countries outside of the United
States and, assuming completion of the transactions
announced today, will have grown from serving 23,000 patients in
2017 to serving more than 79,000 patients.
About DaVita Inc.
DaVita (NYSE: DVA) is a health care
provider focused on transforming care delivery to improve quality
of life for patients globally. The company is one of the largest
providers of kidney care services in the U.S. and has been a leader
in clinical quality and innovation for more than 20 years. DaVita
cares for patients at every stage and setting along their kidney
health journey—from slowing the progression of kidney disease to
helping to support transplantation, from acute hospital care to
dialysis at home. As of December 31, 2023, DaVita served
approximately 250,200 patients at 3,042 outpatient dialysis
centers, of which 2,675 centers were located
in the United States and 367 centers were located in 11
other countries worldwide. DaVita has reduced hospitalizations,
improved mortality, and worked collaboratively to propel the kidney
care industry to adopt an equitable and high-quality standard of
care for all patients, everywhere. To learn more,
visit DaVita.com/About.
This press release contains forward-looking statements within
the meaning of the federal securities laws. All such statements in
this press release, other than statements of historical fact,
including, without limitation, statements about the anticipated
effects of the transactions described herein and the timing of
closing, are forward-looking statements. Words such as "expect,"
"intend," "will," "plan," "anticipate," "may," "believe,"
"continue," and similar expressions are intended to identify
forward-looking statements. DaVita bases its forward-looking
statements on information available to it on the date of this
release and undertakes no obligation to publicly update or revise
any forward-looking statements, whether as a result of changed
circumstances, new information, future events or otherwise, except
as may otherwise be required by law. Actual results and other
events could differ materially from any forward-looking statements
due to numerous factors that involve substantial known and unknown
risks and uncertainties. These risks and uncertainties include,
among other things, the risk factors set forth in the reports on
Form 10-K and Form 10-Q filed by DaVita, and the other risks and
uncertainties discussed in any subsequent reports that DaVita files
with the Securities and Exchange Commission from time to
time.
Media Contact:
Doug
MacDougall, Head of Corporate Affairs, DaVita
International
Doug.MacDougall@Davita.com
+1 303 809 7785
Logo -
https://mma.prnewswire.com/media/398805/DAVITAjpg_Logo.jpg
View original
content:https://www.prnewswire.co.uk/news-releases/davita-enters-into-agreement-to-expand-operations-in-brazil-and-colombia-enter-chile-and-ecuador-302079292.html